Cited by 98Pituitary Gland Disorders and TreatmentsBone health and osteoporosis researchGrowth Hormone and Insulin-like Growth Factors

High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas

Mazziotti, Gherardo, Mancini, Tatiana, Mormando, Marilda, De Menis, Ernesto, Bianchi, Antonio, Doga, Mauro, Porcelli, Teresa, Vescovi, Pier Paolo +2 more·2011·Pituitary

Abstract

Hyperprolactinemia may cause bone loss but data on fractures are scanty. The aim of this study was to evaluate the prevalence of vertebral fractures in women with prolactin (PRL)-secreting adenoma. In this cross-sectional study, 78 women (median age 45.5 years, range: 20-81) with PRL-secreting pituitary adenoma (66 with microadenoma and 12 with macroadenoma) and 156 control subjects, with normal PRL values and with comparable age to patients with hyperprolactinemia, were evaluated for vertebral fractures by a morphometric approach and for bone mineral density (BMD) by a dual-energy X-ray absorptiometry at lumbar spine. Vertebral fractures were shown in 25 patients with PRL-secreting adenoma (32.6%) and in 20 controls (12.8%, P < 0.001). Fractured patients were significantly older (P < 0.001) and had lower BMD T-score (P < 0.001), longer duration of disease (P < 0.001), higher serum PRL (P = 0.004) and lower serum IGF-I (P < 0.001) values as compared to patients who did not fracture. The prevalence of vertebral fractures was significantly (P < 0.001) higher in post-menopausal women with PRL-secreting adenoma as compared to pre-menopausal patients. Fractures occurred more frequently (P = 0.01) in patients with untreated hyperprolactinemia versus patients treated with cabergoline. Logistic regression analysis demonstrated that duration of disease maintained a significant correlation with vertebral fractures (odds ratio 1.16, C.I. 95% 1.02-1.33) even after correction for age, men…

Integrity signals

Registry

Crossref · 10.1007/s11102-011-0293-4

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher prevalence of radiological vertebral fractures occurs in women and men with PRL-secreting adenomas compared to controls.

    “Mazziotti et al. have shown that higher prevalence of radiological vertebral fractures (VFs) occurs in women and men with PRL-secreting adenomas compared to controls [18, 24].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [24]

  • Fractures were more frequent in patients with untreated hyperprolactinemia in comparison with patients treated with cabergoline.

    “Fractures were more frequent in patients with untreated hyperprolactinemia in comparison with patients treated with cabergoline [18, 24].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [24]

  • In female patients, prevalence of vertebral fractures was associated with duration of disease independently of hypopituitarism, age, BMD, serum PRL levels, and treatment with dopaminergic drugs.

    “In female patients prevalence of VFs was associated with the duration of the disease independently of the effects of hypopituitarism, age, BMD, serum PRL levels, and treatment with dopaminergic drugs [24].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [24]

The citation lists haven’t been fetched yet

References 50 · Cited by 98

Authors
Mazziotti, G., Mancini, T., Mormando, M., De Menis, E., Bianchi, A., Doga, M., Porcelli, T., Vescovi, P. P., De Marinis, L., & Giustina, A.
Affiliations
  • University of Brescia (IT)
  • Ospedale di Stato della Repubblica di San Marino (SM)
  • Azienda Ospedaliera Carlo Poma (IT)
Corresponding author
Giustina, Andrea
Venue
Pituitary
Published
2011-02-08
Volume
14
Issue
4
Pages
299-306
ISSN
  • 1386-341X (ISSN-L)
  • 1573-7403
OpenAlex
W2052999878
Cited by
98
References
50
Citations by year
2026: 7 · 2025: 6 · 2024: 13 · 2023: 9 · 2022: 4 · 2021: 11 · 2020: 2 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 3 · 2014: 6 · 2013: 4 · 2012: 5
FWCI
4.72
Type
journal article
Language
en
Open access
closed
Locations
  • Pituitary (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Funders
Ministero dell’Istruzione, dell’Università e della Ricerca
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
prolactinoma, hyperprolactinemia, vertebral fractures, bone loss, bone mineral density, insulin-like growth factor I, cabergoline, postmenopausal women, disease duration, pituitary adenoma
MeSH terms
Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Lumbar Vertebrae, Middle Aged, Pituitary Neoplasms, Prolactinoma, Absorptiometry, Photon, Bone Density, Prevalence, Spinal Fractures, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review